Citadel Advisors’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8M | Sell |
2,337,517
-162,830
| -7% | -$2.77M | 0.01% | 606 |
|
|
2025
Q1 | $48.8M | Buy |
2,500,347
+438,101
| +21% | +$8.56M | 0.01% | 486 |
|
|
2024
Q4 | $51.1M | Buy |
2,062,246
+566,051
| +38% | +$14M | 0.01% | 528 |
|
|
2024
Q3 | $36.7M | Buy |
1,496,195
+727,041
| +95% | +$17.8M | 0.01% | 606 |
|
|
2024
Q2 | $18M | Buy |
769,154
+729,641
| +1,847% | +$17.1M | ﹤0.01% | 915 |
|
|
2024
Q1 | $1.31M | Buy |
39,513
+28,068
| +245% | +$927K | ﹤0.01% | 2905 |
|
|
2023
Q4 | $312K | Sell |
11,445
-1,165,470
| -99% | -$31.7M | ﹤0.01% | 4211 |
|
|
2023
Q3 | $28.3M | Buy |
1,176,915
+857,371
| +268% | +$20.6M | 0.01% | 650 |
|
|
2023
Q2 | $10.2M | Buy |
319,544
+138,344
| +76% | +$4.42M | ﹤0.01% | 1198 |
|
|
2023
Q1 | $5.55M | Buy |
181,200
+51,938
| +40% | +$1.59M | ﹤0.01% | 1729 |
|
|
2022
Q4 | $5.06M | Buy |
129,262
+34,930
| +37% | +$1.37M | ﹤0.01% | 1786 |
|
|
2022
Q3 | $4.49M | Buy |
94,332
+41,000
| +77% | +$1.95M | ﹤0.01% | 1961 |
|
|
2022
Q2 | $2.06M | Sell |
53,332
-111,186
| -68% | -$4.3M | ﹤0.01% | 2705 |
|
|
2022
Q1 | $9.43M | Buy |
164,518
+83,789
| +104% | +$4.8M | ﹤0.01% | 1455 |
|
|
2021
Q4 | $6.43M | Sell |
80,729
-135,463
| -63% | -$10.8M | ﹤0.01% | 1876 |
|
|
2021
Q3 | $18.8M | Buy |
216,192
+194,580
| +900% | +$16.9M | ﹤0.01% | 954 |
|
|
2021
Q2 | $2.78M | Sell |
21,612
-135,705
| -86% | -$17.5M | ﹤0.01% | 2847 |
|
|
2021
Q1 | $12.6M | Buy |
157,317
+147,684
| +1,533% | +$11.8M | ﹤0.01% | 1269 |
|
|
2020
Q4 | $786K | Buy |
+9,633
| New | +$786K | ﹤0.01% | 3487 |
|
|
2020
Q3 | – | Sell |
-27,126
| Closed | -$759K | – | 4669 |
|
|
2020
Q2 | $759K | Sell |
27,126
-59,173
| -69% | -$1.66M | ﹤0.01% | 3106 |
|
|
2020
Q1 | $1.55M | Buy |
+86,299
| New | +$1.55M | ﹤0.01% | 2454 |
|